Several attempts were performed whether BRCA1/2 mutation carriers with radiotherapy display higher incidence of secondary malignancy comparing BRCA1/2 mutation carriers with mastectomy or sporadic breast cancer patients. This evidence concerns the gene BRCA1 and breast cancer.